Slokdarmkanker

Bronnen en Literatuur

Bronnen

• CBS Doodsoorzakenstatistiek. Gegevens omtrent de doodsoorzaken van alle in Nederlandse bevolkingsregisters ingeschreven overledenen.
• CBS StatLine. De elektronische databank van het CBS. Bevat statistische informatie over vele maatschappelijke en economische onderwerpen in de vorm van tabellen en grafieken.
• EUCAN. European network of Cancer Registries (IARC)
• EUROCARE. EUROCARE (IARC)
• Eurostat. Statistische Database van de Europese Unie
• IKA. Kankerregistratie IKA-regio (Noord-Holland en Flevoland)
• IKZ. Kankerregistratie IKZ-regio (Noord-Brabant en Noord-Limburg).
• LMR. Landelijke Medische Registratie (Dutch Hospital Data).
• NKR. Nederlandse Kanker Registratie

Literatuur

• Ahsan N, Neugut AI.Radiation therapy for breast cancer and increased risk for esophageal carcinoma. Ann Intern Med., 1998; 128(2): 114-117.
• Blot WJ. Esophageal cancer trends and risk factors. Semin Oncol,1994; 21(4): 403-410.
• Boer AG de, Genovesi PI, Sprangers MAG, Sandick JW van, Obertop H, Lanschot JJB van. Quality of life in long-term survivors after curative transhiatal oesophagectomy for oesophagal carcinoma. Br J Surg2000; 87: 1716-21.
• Botterweck AAM, Schouten LJ, Volovics A, Dorant E, Van den Brandt PA.Trends in incidence of adenocarcinoma of the oesophagus and gastric cardia in ten European countries. Int J Epidemiol 2000; 29: 645-654.
• Chow WH, Blaser MJ, Blot WJ, Gammon MD, Vaughan TL, Risch HA, et al. An inverse relation between cagA+ strains of Helicobacter pylori infection and risk of esophageal and gastric cardia adenocarcinoma. Cancer Res,1998b; 58(4): 588-590.
• Chow WH, Blot WJ, Vaughan TL, Risch HA, Gammon MD, Stanford JL, et al. Body mass index and risk of adenocarcinomas of the esophagus and gastric cardia. J Natl Cancer Inst,1998a; 90(2): 150-155.
• Corley DA, Kerlikowske K, Verma R, Buffler P. Protective association of aspirin/NSAIDs and esophageal cancer: a systematic review and meta-analysis. Gastroenterology,2003; 124(1): 47-56.
• Dal Maso L, Vecchia C la, Polesel J, Talamini R, Levi F, Conti E. Alcohol drinking outside meals and cancers of the upper aero-digestive tract. Int J Cancer2002; 102(4): 435-7.
• El-Serag HB, Sonnenberg A.Associations between different forms of gastro-oesophageal reflux disease. Gut, 1997; 41: 594-9.
• Farhadi M, Thamasebi Z, Merat S, Kamangar F, Nasrollahzadeh D, Malekzadeh R. Human papillomavirus in squamous cell carcinoma of esophagus in a high-risk population. World J Gastroenterol,2005; 11(8): 1200-1203.
• Gonzalez CA, Pera G, Agudo A, Bueno-de-Mesquita HB, Ceroti M, Boeing H, et al. Fruit and vegetable intake and the risk of stomach and oesophagus adenocarcinoma in the European Prospective Investigation into Cancer and Nutrition (EPIC-EURGAST). Int J Cancer,2006; 118(10): 2559-2566.
• Hamilton S, Aaltonen L.WHO classification of tumours, Pathology & Genetics, Tumours of the digestive system. Geneva: WHO, 2000.
• Hampel H, Abraham NS, El Seraq HB. Meta-analysis: obesity and the risk for gastroesophageal reflux disease and its complications. Ann Intern Med,2005; 143(3): 199-211.
• Hulscher JB, Sandick JW van, Boer AG de, Wijnhoven BP, Tijssen JG, Fockens P, et al.Extended transthoracic resection compared with limited transhiatal resection for adenocarcinoma of the esophagus. N Engl J Med, 2002; 347(21): 1662-1669.
• Hur C, Nishioka NS, Gazelle GS. Cost-effectiveness of aspirin chemoprevention for Barrett's esophagus. J Natl Cancer Inst,2004; 96(4): 316-325.
• IKZ, Integraal Kankercentrum Zuid.Van meten naar weten; 50 jaar kankerregistratie. Eindhoven: IKZ, 2005.
• Kok TC, Nooter K, Tjong AHS, Smits HL, Schegget JT ter. No evidence of known types of human papillomavirus in squamous cell cancer of the oesophagus in a low-risk area. Rotterdam Oesophageal Tumour Study Group. Eur J Cancer,1997a; 33(11): 1865-1868.
• Kubo A, Corley DA. Body mass index and adenocarcinomas of the esophagus or gastric cardia: a systematic review and meta-analysis. Cancer Epidemiol Biomarkers Prev,2006; 15(5): 872-8.
• La Vecchia C, Negri E, Levi F, Decarli A, Boyle P.Cancer mortality in Europe: effects of age, cohort of birth and period of death. Eur J Cancer 1998; 34(1): 118-41.
• Lagergren J, Bergstrom R, Lindgren A, Nyren O.Symptomatic gastroesophageal reflux as a risk factor for esophageal adenocarcinoma. N Engl J Med 1999a; 340: 825-31.
• Lagergren J, Bergstrom R, Nyren O.Association between body mass and adenocarcinoma of the esophagus and gastric cardia. Ann Intern Med 1999b; 130: 883-90.
• Lanschot JJ van (red.).Cancer of the esophagus and gastroesophageal junction In: Integrated Medical And Surgical Gastro-enterology. Houten: Bohn Stafleu en van Loghum, 2004.
• Levi F, Lucchini F, Negri E, Boyle P, La Vecchia C.Cancer mortality in Europe, 1990-1994, and an overview of trends from 1955 to 1994. Eur J Cancer 1999; 35(10): 1477-516.
• Lunet N, Lacerda-Vieira A, Barros H. Fruit and vegetables consumption and gastric cancer: a systematic review and meta-analysis of cohort studies. Nutr Cancer,2005; 53(1): 1-10.
• Martin IG, Young S, Sue-Ling H, Johnston D. Delays in the diagnosis of oesophagogastric cancer: a consecutive case series. BMJ,1997; 314(7079): 467-470.
• McRonald FE, Liloglou T, Xinarianos G, Hill L, Rowbottom L, Langan JE, et al. Down-regulation of the cytoglobin gene, located on 17q25, in tylosis with oesophageal cancer (TOC): evidence for trans-allele repression. Hum Mol Genet,2006; 15(8): 1271-1277.
• NKR, Nederlandse Kanker Registratie.NKR. http: //www.ikcnet.nl (geraadpleegd februari 2005). Utrecht: NKR, 2004.
• Poos MJJC, Smit JM, Groen J, Kommer GJ, Slobbe LCJ. Kosten van ziekten in Nederland 2005. RIVM-rapport nr. 270751019. Bilthoven: RIVM,2008.
• Rosenberg JC, Lichter AS, Leichman LP.Cancer of the esophagus. In: DeVita VT, Hellman S, Rosenberg SA (eds.). Cancer, principles and practice of oncology 7th edition Philadelphia: JB Lippencott Company, 2005: 725-764.
• Sampliner RE. Updated guidelines for the diagnosis, surveillance, and therapy of Barrett's esophagus. Am J Gastroenterol,2002; 97(8): 1888-1895.
• Sandick JW van, Lanschot JJ van, Kuiken BW, Tytgat GN, Offerhaus GJ, Obertop H, et al. Impact of endoscopic biopsy surveillance of Barrett's oesophagus on pathological stage and clinical outcome of Barrett's carcinoma. Gut,1998; 43(2): 216-222.
• Sandick JW van, Obertop H, Fockens P, Kesecioglu J, Overdijk LE, Lanschot JJ van, et al. Transhiatal esophagus resection without thoracotomy for carcinoma: complications, hospital mortality and prognosis in 115 patients. Ned Tijdschr Geneeskd,2000; 144(43): 2061-2066.
• Sant M, Aareleid T, Berrino F, Bielska Lasota M, Carli PM, Faivre J, et al.EUROCARE-3: survival of cancer patients diagnosed 1990-94. Results and commentary. Ann Oncol, 2003a; 14(Suppl 5): v61-118.
• Siersema PD, Verschuur EM, Homs MY, Gaast A van der, Eijkenboom WM, Kuipers EJ, et al. Palliative treatment in patients with oesophagus carcinoma. Ned Tijdschr Geneeskd,2005; 149(50): 2775-2782.
• Soest EM van, Dieleman JP, Siersema PD, Sturkenboom MC, Kuipers EJ. Increasing incidence of Barrett's oesophagus in the general population. Gut,2005; 54(8): 1062-1066.
• UICC, International Union Against Cancer.TNM classification of malignant tumours, 6th edition, 2002. Berlijn: Springer-Verlag, 2002.
• VIKC, Vereniging van Integrale Kankercentra.Feiten + Fabels over kanker in Nederland. Utrecht: VIKC, 2005.
• WCRF & AICR, World Cancer Research Fund & American Institute for Cancer Research.Food, nutrition, and the prevention of cancer: a global perspective. Washington DC: AICR, 1997.
• Westerterp M, Westreenen HL van, Sloof GW, Plukker JT, Lanschot JJ van. Role of positron emission tomography in the (re-)staging of oesophageal cancer. Scand J Gastroenterol Suppl,2006; (243): 116-122.
• Wijnhoven BPL, Tran K, Esterman A, Watson DI, Tilanus HW.An evaluation of prognostic factors and staging in resected carcinoma of the esophagus. Annals of Surgery, 2007; 245(5): 717-25.
• Wijnhoven BPL.Cancer of the esophagus and gastroesophageal junciton.In: Integrated Medical And Surgical Gastro-enterology Eds. van Lanschot et al. Houten: Bohn, Stafleu en van Loghum, 2004.
• Wu AH, Crabtree JE, Bernstein L, Hawtin P, Cockburn M, Tseng CC, et al. Role of Helicobacter pylori CagA+ strains and risk of adenocarcinoma of the stomach and esophagus. Int J Cancer,2003; 103(6): 815-821.
• Ye W, Held M, Lagergren J, Engstrand L, Blot WJ, McLaughlin JK, et al. Helicobacter pylori infection and gastric atrophy: risk of adenocarcinoma and squamous-cell carcinoma of the esophagus and adenocarcinoma of the gastric cardia. J Natl Cancer Inst,2004; 96(5): 388-396.